| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tumor Suppressor Protein p53 | 13 | 2023 | 3552 | 1.910 |
Why?
|
| NF-E2-Related Factor 2 | 10 | 2016 | 249 | 1.650 |
Why?
|
| Embryonic Stem Cells | 5 | 2018 | 301 | 1.540 |
Why?
|
| Gene Expression Regulation | 12 | 2022 | 4053 | 1.130 |
Why?
|
| Tyrosine | 3 | 2016 | 498 | 1.020 |
Why?
|
| Cell Nucleus | 9 | 2016 | 1620 | 0.910 |
Why?
|
| RNA, Long Noncoding | 2 | 2020 | 598 | 0.890 |
Why?
|
| Protein Processing, Post-Translational | 4 | 2016 | 803 | 0.830 |
Why?
|
| Chromatin | 6 | 2023 | 942 | 0.770 |
Why?
|
| Human Genome Project | 1 | 2021 | 64 | 0.770 |
Why?
|
| Histones | 4 | 2022 | 1466 | 0.740 |
Why?
|
| Pluripotent Stem Cells | 2 | 2018 | 123 | 0.690 |
Why?
|
| Databases, Genetic | 3 | 2022 | 745 | 0.670 |
Why?
|
| Chromosomal Proteins, Non-Histone | 2 | 2022 | 362 | 0.650 |
Why?
|
| Cell Differentiation | 5 | 2023 | 4078 | 0.620 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 3 | 2016 | 507 | 0.610 |
Why?
|
| Ubiquitin-Protein Ligases | 4 | 2010 | 854 | 0.570 |
Why?
|
| Transcription, Genetic | 5 | 2020 | 3154 | 0.560 |
Why?
|
| Genetic Variation | 2 | 2022 | 2086 | 0.540 |
Why?
|
| Transcription Factors | 9 | 2024 | 5270 | 0.510 |
Why?
|
| Cell Cycle | 2 | 2012 | 2084 | 0.510 |
Why?
|
| Genes, p53 | 1 | 2018 | 1090 | 0.460 |
Why?
|
| Software | 1 | 2021 | 1321 | 0.460 |
Why?
|
| Genome, Human | 2 | 2021 | 1869 | 0.440 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2014 | 430 | 0.420 |
Why?
|
| Ubiquitin | 2 | 2010 | 344 | 0.390 |
Why?
|
| Carrier Proteins | 2 | 2021 | 2022 | 0.380 |
Why?
|
| Protein Binding | 7 | 2020 | 3438 | 0.380 |
Why?
|
| Antioxidants | 6 | 2016 | 507 | 0.380 |
Why?
|
| Proto-Oncogene Proteins c-fyn | 2 | 2007 | 31 | 0.370 |
Why?
|
| Nuclear Proteins | 4 | 2022 | 3343 | 0.340 |
Why?
|
| MicroRNAs | 2 | 2012 | 2947 | 0.330 |
Why?
|
| Active Transport, Cell Nucleus | 6 | 2011 | 323 | 0.320 |
Why?
|
| Glycogen Synthase Kinase 3 | 2 | 2011 | 161 | 0.310 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2010 | 589 | 0.300 |
Why?
|
| DNA Damage | 2 | 2014 | 1954 | 0.290 |
Why?
|
| Models, Animal | 1 | 2009 | 664 | 0.290 |
Why?
|
| Oxidative Stress | 3 | 2008 | 1129 | 0.290 |
Why?
|
| Acetylation | 3 | 2022 | 508 | 0.270 |
Why?
|
| Whole Genome Sequencing | 3 | 2024 | 338 | 0.260 |
Why?
|
| Cell Line, Tumor | 13 | 2022 | 14551 | 0.250 |
Why?
|
| Animals | 24 | 2023 | 59536 | 0.250 |
Why?
|
| src-Family Kinases | 3 | 2016 | 478 | 0.250 |
Why?
|
| Homeodomain Proteins | 2 | 2022 | 1143 | 0.240 |
Why?
|
| Mice | 19 | 2023 | 34495 | 0.230 |
Why?
|
| India | 2 | 2022 | 301 | 0.230 |
Why?
|
| Phosphorylation | 6 | 2014 | 4804 | 0.220 |
Why?
|
| Infant Mortality | 1 | 2024 | 186 | 0.220 |
Why?
|
| Neoplasms | 4 | 2020 | 15193 | 0.220 |
Why?
|
| DNA-Binding Proteins | 3 | 2022 | 4821 | 0.210 |
Why?
|
| Prolyl Hydroxylases | 1 | 2021 | 7 | 0.210 |
Why?
|
| Li-Fraumeni Syndrome | 1 | 2023 | 158 | 0.210 |
Why?
|
| Apoptosis | 5 | 2023 | 7591 | 0.210 |
Why?
|
| Trans-Activators | 2 | 2005 | 1555 | 0.200 |
Why?
|
| Genome, Viral | 1 | 2022 | 155 | 0.200 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2018 | 1498 | 0.190 |
Why?
|
| Ubiquitination | 3 | 2014 | 575 | 0.190 |
Why?
|
| Humans | 31 | 2024 | 261506 | 0.190 |
Why?
|
| Tripartite Motif-Containing Protein 28 | 1 | 2020 | 32 | 0.180 |
Why?
|
| Interferon Regulatory Factor-1 | 1 | 2020 | 53 | 0.180 |
Why?
|
| Carcinosarcoma | 1 | 2021 | 146 | 0.180 |
Why?
|
| Molecular Sequence Annotation | 1 | 2021 | 201 | 0.180 |
Why?
|
| Aldehyde Oxidase | 1 | 2019 | 8 | 0.180 |
Why?
|
| Lysine | 1 | 2022 | 422 | 0.180 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2023 | 621 | 0.180 |
Why?
|
| Genetics, Population | 1 | 2021 | 242 | 0.180 |
Why?
|
| Host-Pathogen Interactions | 1 | 2022 | 314 | 0.170 |
Why?
|
| STAT1 Transcription Factor | 1 | 2020 | 156 | 0.170 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2022 | 305 | 0.160 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2021 | 494 | 0.160 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 1 | 2019 | 245 | 0.160 |
Why?
|
| Muscular Dystrophy, Facioscapulohumeral | 1 | 2017 | 5 | 0.160 |
Why?
|
| Myoblasts, Skeletal | 1 | 2017 | 18 | 0.150 |
Why?
|
| Evolution, Molecular | 1 | 2022 | 834 | 0.150 |
Why?
|
| Antibiotics, Antineoplastic | 2 | 2014 | 726 | 0.150 |
Why?
|
| Sirtuins | 1 | 2016 | 44 | 0.150 |
Why?
|
| Mitochondria | 1 | 2024 | 1282 | 0.140 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2023 | 1331 | 0.140 |
Why?
|
| Urinary Bladder | 1 | 2019 | 575 | 0.140 |
Why?
|
| Plasmids | 3 | 2008 | 837 | 0.140 |
Why?
|
| Internet | 1 | 2021 | 706 | 0.140 |
Why?
|
| Immunoblotting | 3 | 2009 | 886 | 0.140 |
Why?
|
| Genes, Reporter | 3 | 2008 | 798 | 0.140 |
Why?
|
| Gene Regulatory Networks | 1 | 2020 | 677 | 0.140 |
Why?
|
| Cellular Reprogramming | 1 | 2018 | 189 | 0.140 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2019 | 622 | 0.140 |
Why?
|
| Exome | 1 | 2021 | 1239 | 0.130 |
Why?
|
| Histone Deacetylases | 1 | 2016 | 365 | 0.120 |
Why?
|
| Dactinomycin | 1 | 2014 | 145 | 0.120 |
Why?
|
| Protein Stability | 2 | 2012 | 370 | 0.120 |
Why?
|
| Epigenesis, Genetic | 3 | 2023 | 1399 | 0.110 |
Why?
|
| B7-H1 Antigen | 1 | 2020 | 1022 | 0.110 |
Why?
|
| Transfection | 3 | 2008 | 2944 | 0.110 |
Why?
|
| Drosophila Proteins | 2 | 2009 | 858 | 0.110 |
Why?
|
| Serine | 1 | 2014 | 388 | 0.110 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2009 | 1265 | 0.110 |
Why?
|
| MCF-7 Cells | 1 | 2014 | 550 | 0.110 |
Why?
|
| Mice, Knockout | 3 | 2018 | 5710 | 0.110 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2023 | 1724 | 0.110 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2021 | 1215 | 0.100 |
Why?
|
| Binding Sites | 2 | 2013 | 2171 | 0.100 |
Why?
|
| Antigens, Differentiation | 1 | 2012 | 238 | 0.100 |
Why?
|
| Models, Biological | 2 | 2010 | 3254 | 0.100 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 2 | 2011 | 163 | 0.100 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2019 | 2359 | 0.090 |
Why?
|
| Cell Lineage | 2 | 2023 | 668 | 0.090 |
Why?
|
| Dimerization | 2 | 2008 | 304 | 0.090 |
Why?
|
| RNA, Small Interfering | 2 | 2007 | 2216 | 0.090 |
Why?
|
| Mass Spectrometry | 2 | 2009 | 702 | 0.090 |
Why?
|
| Hydroquinones | 1 | 2009 | 28 | 0.090 |
Why?
|
| Signal Transduction | 4 | 2022 | 11965 | 0.090 |
Why?
|
| HEK293 Cells | 1 | 2014 | 1489 | 0.090 |
Why?
|
| Muscle, Skeletal | 1 | 2017 | 1270 | 0.090 |
Why?
|
| Tretinoin | 1 | 2012 | 623 | 0.090 |
Why?
|
| Embryo, Mammalian | 1 | 2012 | 741 | 0.090 |
Why?
|
| Cell Line | 4 | 2017 | 5114 | 0.080 |
Why?
|
| Biomarkers | 1 | 2020 | 5047 | 0.080 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2016 | 2488 | 0.080 |
Why?
|
| Fibroblasts | 2 | 2012 | 1682 | 0.080 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 2 | 2006 | 60 | 0.080 |
Why?
|
| Cell Death | 2 | 2023 | 671 | 0.080 |
Why?
|
| Drug Resistance | 1 | 2009 | 587 | 0.080 |
Why?
|
| Protein Transport | 2 | 2009 | 734 | 0.080 |
Why?
|
| Alanine | 1 | 2008 | 240 | 0.080 |
Why?
|
| Drosophila | 2 | 2009 | 839 | 0.080 |
Why?
|
| Base Sequence | 2 | 2012 | 4917 | 0.080 |
Why?
|
| Luciferases | 2 | 2005 | 445 | 0.070 |
Why?
|
| Doxorubicin | 1 | 2014 | 3005 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 2 | 2012 | 3101 | 0.070 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2019 | 2341 | 0.070 |
Why?
|
| NADPH Dehydrogenase | 1 | 2006 | 10 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2021 | 8873 | 0.070 |
Why?
|
| Pancreatic Neoplasms | 1 | 2023 | 5061 | 0.070 |
Why?
|
| Microscopy, Fluorescence | 2 | 2005 | 769 | 0.070 |
Why?
|
| Nuclear Localization Signals | 1 | 2005 | 46 | 0.070 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2006 | 182 | 0.070 |
Why?
|
| Hydrogen Peroxide | 1 | 2006 | 217 | 0.070 |
Why?
|
| Cell Culture Techniques | 1 | 2008 | 598 | 0.060 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2005 | 94 | 0.060 |
Why?
|
| Karyopherins | 1 | 2006 | 136 | 0.060 |
Why?
|
| Cytosol | 1 | 2005 | 238 | 0.060 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2005 | 568 | 0.060 |
Why?
|
| Immunoprecipitation | 1 | 2006 | 591 | 0.060 |
Why?
|
| Luminescent Proteins | 1 | 2005 | 289 | 0.060 |
Why?
|
| Prostatic Neoplasms | 1 | 2021 | 5767 | 0.060 |
Why?
|
| Up-Regulation | 2 | 2008 | 2450 | 0.060 |
Why?
|
| Biological Transport | 1 | 2005 | 597 | 0.060 |
Why?
|
| Peroxisome Proliferator-Activated Receptors | 1 | 2023 | 25 | 0.060 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2023 | 6915 | 0.060 |
Why?
|
| Gene Deletion | 2 | 2006 | 1442 | 0.060 |
Why?
|
| Molecular Sequence Data | 2 | 2008 | 6089 | 0.060 |
Why?
|
| Cells, Cultured | 1 | 2012 | 5637 | 0.060 |
Why?
|
| Green Fluorescent Proteins | 1 | 2005 | 694 | 0.060 |
Why?
|
| Molecular Chaperones | 1 | 2024 | 264 | 0.050 |
Why?
|
| Chromatin Immunoprecipitation | 3 | 2009 | 518 | 0.050 |
Why?
|
| Nucleosomes | 1 | 2023 | 143 | 0.050 |
Why?
|
| DNA Repair Enzymes | 1 | 2024 | 237 | 0.050 |
Why?
|
| APOBEC-1 Deaminase | 1 | 2022 | 10 | 0.050 |
Why?
|
| Neoplasm Invasiveness | 2 | 2021 | 3981 | 0.050 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2019 | 5319 | 0.050 |
Why?
|
| Adenosine Deaminase | 1 | 2022 | 94 | 0.050 |
Why?
|
| Vero Cells | 1 | 2022 | 143 | 0.050 |
Why?
|
| Disease Models, Animal | 3 | 2020 | 7222 | 0.050 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2021 | 3821 | 0.050 |
Why?
|
| Amino Acid Sequence | 1 | 2008 | 4233 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 1 | 2005 | 1487 | 0.050 |
Why?
|
| Immune Evasion | 1 | 2022 | 73 | 0.050 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2006 | 591 | 0.050 |
Why?
|
| Mitochondrial Proteins | 1 | 2024 | 369 | 0.050 |
Why?
|
| Adenosine Triphosphate | 1 | 2023 | 571 | 0.050 |
Why?
|
| Hyaluronan Receptors | 1 | 2022 | 249 | 0.050 |
Why?
|
| Primary Cell Culture | 1 | 2021 | 208 | 0.050 |
Why?
|
| Receptor, Notch1 | 1 | 2022 | 218 | 0.050 |
Why?
|
| Photosensitizing Agents | 1 | 2020 | 71 | 0.040 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2022 | 222 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2005 | 1555 | 0.040 |
Why?
|
| Phylogeny | 1 | 2022 | 826 | 0.040 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2019 | 69 | 0.040 |
Why?
|
| NADP | 1 | 2019 | 96 | 0.040 |
Why?
|
| Tryptophan | 1 | 2019 | 127 | 0.040 |
Why?
|
| Kynurenine | 1 | 2019 | 71 | 0.040 |
Why?
|
| Bacterial Proteins | 1 | 2005 | 1029 | 0.040 |
Why?
|
| Cell Division | 1 | 2023 | 2489 | 0.040 |
Why?
|
| Nucleotides | 1 | 2019 | 164 | 0.040 |
Why?
|
| Transcriptional Activation | 1 | 2023 | 1070 | 0.040 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2022 | 461 | 0.040 |
Why?
|
| Kelch-Like ECH-Associated Protein 1 | 2 | 2009 | 104 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2021 | 419 | 0.040 |
Why?
|
| Female | 4 | 2024 | 141928 | 0.040 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 470 | 0.040 |
Why?
|
| Energy Metabolism | 1 | 2024 | 992 | 0.040 |
Why?
|
| Mammary Glands, Animal | 1 | 2021 | 533 | 0.040 |
Why?
|
| Mutation | 3 | 2009 | 15179 | 0.040 |
Why?
|
| Tissue Array Analysis | 1 | 2019 | 760 | 0.040 |
Why?
|
| Heterografts | 1 | 2019 | 733 | 0.040 |
Why?
|
| Lung Neoplasms | 1 | 2019 | 11538 | 0.040 |
Why?
|
| Male | 3 | 2021 | 123000 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 1077 | 0.040 |
Why?
|
| RNA-Binding Proteins | 1 | 2022 | 984 | 0.030 |
Why?
|
| Response Elements | 2 | 2007 | 193 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2017 | 528 | 0.030 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2023 | 1586 | 0.030 |
Why?
|
| Metabolomics | 1 | 2019 | 478 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2022 | 1678 | 0.030 |
Why?
|
| DNA | 1 | 2023 | 2693 | 0.030 |
Why?
|
| Breast | 1 | 2021 | 1344 | 0.030 |
Why?
|
| Adult | 1 | 2021 | 77950 | 0.030 |
Why?
|
| Time Factors | 2 | 2005 | 12926 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 7548 | 0.030 |
Why?
|
| Cell Movement | 1 | 2021 | 2466 | 0.030 |
Why?
|
| Autophagy | 1 | 2020 | 927 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2021 | 4143 | 0.030 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2006 | 2027 | 0.030 |
Why?
|
| Computational Biology | 1 | 2019 | 1271 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2022 | 2045 | 0.030 |
Why?
|
| Genomics | 1 | 2024 | 2738 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2020 | 4307 | 0.030 |
Why?
|
| Histone Demethylases | 1 | 2013 | 144 | 0.030 |
Why?
|
| Oxidants | 1 | 2011 | 49 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2021 | 5112 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2021 | 3719 | 0.020 |
Why?
|
| Pregnancy | 1 | 2024 | 7573 | 0.020 |
Why?
|
| Protein Kinase C-delta | 1 | 2009 | 42 | 0.020 |
Why?
|
| Chromatography, Gel | 1 | 2009 | 157 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2020 | 6942 | 0.020 |
Why?
|
| Liver Neoplasms | 1 | 2006 | 4557 | 0.020 |
Why?
|
| Ultraviolet Rays | 1 | 2011 | 575 | 0.020 |
Why?
|
| Gene Knock-In Techniques | 1 | 2009 | 171 | 0.020 |
Why?
|
| Infant | 1 | 2024 | 13310 | 0.020 |
Why?
|
| Disease Progression | 1 | 2019 | 6682 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 5159 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2020 | 3869 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2019 | 7226 | 0.020 |
Why?
|
| Mutagenesis | 1 | 2007 | 483 | 0.020 |
Why?
|
| Phenotype | 1 | 2017 | 6295 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2006 | 259 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-maf | 1 | 2005 | 19 | 0.020 |
Why?
|
| Keratinocytes | 1 | 2006 | 241 | 0.020 |
Why?
|
| Fanconi Anemia Complementation Group Proteins | 1 | 2005 | 40 | 0.020 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2005 | 57 | 0.020 |
Why?
|
| Binding, Competitive | 1 | 2005 | 300 | 0.020 |
Why?
|
| Subcellular Fractions | 1 | 2005 | 201 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2006 | 280 | 0.020 |
Why?
|
| Cell Survival | 1 | 2011 | 3045 | 0.020 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2006 | 334 | 0.020 |
Why?
|
| Heme | 1 | 2005 | 78 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 2005 | 682 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2019 | 13658 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 5539 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2005 | 652 | 0.010 |
Why?
|
| Child | 1 | 2024 | 29154 | 0.010 |
Why?
|
| Kinetics | 1 | 2005 | 2049 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 2005 | 889 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2006 | 1538 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2005 | 2074 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2009 | 2669 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2006 | 1549 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2005 | 3536 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2005 | 6150 | 0.010 |
Why?
|